autism drug

Zelira executives believe they have a quicker and less expensive path to get their new drug approved. Zelira Therapeutics is working to begin human clinical testing of its experimental autism spectrum disorder drug next year, but it is not traveling the route pharmaceutical companies typically take to advance a lead product candidate. The 5-year-old drug development company … [Read more...] about Montco cannabis company takes different path for approval of autism drug